Autonomix Medical Inc (AMIX)

$1.12 0.00 (N/A)
Market Cap 6.94M
Revenue (ttm) 0.00
Net Income (ttm) -11.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 204,300
Avg Vol 438,798
Day's Range N/A - N/A
Shares Out 6.19M
Stochastic %K 50%
Beta -2.80
Analysts Strong Sell
Price Target $6.60

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices
Sector: Healthcare
Phone: 713 588 6150
Address:
21 Waterway Avenue, Suite 300, The Woodlands, United States
coolmate25
coolmate25 Oct. 24 at 8:04 PM
$AMIX professionals Hold , Shameless Mother truckers sold.
0 · Reply
Rebelking
Rebelking Oct. 24 at 7:04 PM
$AMIX a green candle to end the week.
0 · Reply
coolmate25
coolmate25 Oct. 24 at 4:18 PM
$AMIX
0 · Reply
SMARTR8
SMARTR8 Oct. 24 at 4:09 PM
$AMIX and before you know it, this one will go BOOM BOOM BOOM BOOM 💥
0 · Reply
Rebelking
Rebelking Oct. 24 at 3:22 PM
$AMIX check back in next week.
0 · Reply
Rebelking
Rebelking Oct. 24 at 3:04 PM
$AMIX
0 · Reply
Rebelking
Rebelking Oct. 24 at 3:01 PM
$AMIX this needs to push into and build in the $1.20’s. + $.07-.08 from here. let’s go!
0 · Reply
onions86
onions86 Oct. 23 at 7:03 PM
$AMIX 71K volume 😂 absolutely under the radar
0 · Reply
coolmate25
coolmate25 Oct. 23 at 3:24 PM
$AMIX I am around and monitoring it and always trying lowering my average on dip , soon the big news will be out before it hit back to $5.
0 · Reply
Rebelking
Rebelking Oct. 23 at 3:07 PM
$AMIX no one here.
0 · Reply
Latest News on AMIX
Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Oct 24, 2025, 9:00 AM EDT - 1 day ago

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Oct 16, 2025, 9:15 AM EDT - 9 days ago

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Oct 9, 2025, 8:45 AM EDT - 16 days ago

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Oct 2, 2025, 8:45 AM EDT - 23 days ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Sep 29, 2025, 9:15 AM EDT - 26 days ago

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Sep 4, 2025, 9:00 AM EDT - 7 weeks ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Sep 3, 2025, 8:30 AM EDT - 7 weeks ago

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 7 weeks ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Aug 18, 2025, 9:15 AM EDT - 2 months ago

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 9:00 AM EDT - 2 months ago

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Aug 14, 2025, 8:30 AM EDT - 2 months ago

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 22, 2025, 8:45 AM EDT - 3 months ago

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Jul 21, 2025, 8:45 AM EDT - 3 months ago

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 30, 2025, 8:30 AM EDT - 4 months ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 27, 2025, 8:00 AM EDT - 4 months ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Jun 5, 2025, 8:45 AM EDT - 5 months ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 15, 2025, 8:30 AM EDT - 5 months ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 14, 2025, 9:20 AM EDT - 5 months ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 13, 2025, 9:20 AM EDT - 5 months ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 5, 2025, 8:30 AM EDT - 6 months ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

May 1, 2025, 9:25 AM EDT - 6 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 6 months ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 24, 2025, 8:30 AM EDT - 6 months ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 17, 2025, 5:00 PM EDT - 6 months ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 16, 2025, 8:30 AM EDT - 6 months ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 8, 2025, 8:15 AM EDT - 7 months ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Apr 3, 2025, 8:30 AM EDT - 7 months ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 20, 2025, 8:30 AM EDT - 7 months ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Mar 14, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 20, 2025, 8:30 AM EST - 8 months ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Feb 13, 2025, 8:00 AM EST - 9 months ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 24, 2025, 8:45 AM EST - 9 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 17, 2025, 8:00 AM EST - 10 months ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 15, 2025, 8:30 AM EST - 10 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Jan 13, 2025, 8:30 AM EST - 10 months ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 30, 2024, 8:30 AM EST - 10 months ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Dec 5, 2024, 8:30 AM EST - 11 months ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Nov 25, 2024, 4:00 PM EST - 11 months ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Nov 22, 2024, 9:15 AM EST - 1 year ago

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Nov 11, 2024, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Oct 28, 2024, 12:06 PM EDT - 1 year ago

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Oct 28, 2024, 11:08 AM EDT - 1 year ago

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Oct 25, 2024, 11:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Autonomix Announces Reverse Stock Split

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Autonomix Announces Reverse Stock Split

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Aug 21, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

coolmate25
coolmate25 Oct. 24 at 8:04 PM
$AMIX professionals Hold , Shameless Mother truckers sold.
0 · Reply
Rebelking
Rebelking Oct. 24 at 7:04 PM
$AMIX a green candle to end the week.
0 · Reply
coolmate25
coolmate25 Oct. 24 at 4:18 PM
$AMIX
0 · Reply
SMARTR8
SMARTR8 Oct. 24 at 4:09 PM
$AMIX and before you know it, this one will go BOOM BOOM BOOM BOOM 💥
0 · Reply
Rebelking
Rebelking Oct. 24 at 3:22 PM
$AMIX check back in next week.
0 · Reply
Rebelking
Rebelking Oct. 24 at 3:04 PM
$AMIX
0 · Reply
Rebelking
Rebelking Oct. 24 at 3:01 PM
$AMIX this needs to push into and build in the $1.20’s. + $.07-.08 from here. let’s go!
0 · Reply
onions86
onions86 Oct. 23 at 7:03 PM
$AMIX 71K volume 😂 absolutely under the radar
0 · Reply
coolmate25
coolmate25 Oct. 23 at 3:24 PM
$AMIX I am around and monitoring it and always trying lowering my average on dip , soon the big news will be out before it hit back to $5.
0 · Reply
Rebelking
Rebelking Oct. 23 at 3:07 PM
$AMIX no one here.
0 · Reply
Rebelking
Rebelking Oct. 22 at 3:37 PM
$AMIX down $9 in the past year. WTF.
0 · Reply
Rebelking
Rebelking Oct. 22 at 3:36 PM
$AMIX analyst called $5 price action in late April. What’s different from then? What are the patents worth? Tough no interest from the industry that you’re trying to put out of business. Hope your NYC trip goes well but I doubt much of anything come out of it but for swapped business cards. ”call me…I’ll call you…”
0 · Reply
Rebelking
Rebelking Oct. 22 at 3:08 PM
$AMIX here early. Or am I late?
0 · Reply
Rebelking
Rebelking Oct. 21 at 7:00 PM
$AMIX stay in this channel. $1.08-1.19.
0 · Reply
Rebelking
Rebelking Oct. 21 at 6:58 PM
$AMIX this will pop.
0 · Reply
DianeElmore377
DianeElmore377 Oct. 20 at 4:31 PM
$AMIX scaling diagnostics; AITX scaling automation — a strong week marked by financial discipline and product expansion.
0 · Reply
Rebelking
Rebelking Oct. 20 at 3:03 PM
$AMIX management team, any news or new plans. or just surfing for now.
0 · Reply
Rebelking
Rebelking Oct. 19 at 10:22 PM
$AMIX this company, in a multi-billion dollar pain industry, should $70MM market cap. to start
1 · Reply
Kingcrab3333
Kingcrab3333 Oct. 18 at 9:31 PM
$AMIX
0 · Reply
coolmate25
coolmate25 Oct. 17 at 6:59 PM
$AMIX
0 · Reply
coolmate25
coolmate25 Oct. 17 at 6:58 PM
$AMIX
0 · Reply
Rebelking
Rebelking Oct. 17 at 6:50 PM
$AMIX dude where the f—k is everyone?
0 · Reply